Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Watz, K. M. Beeh, H. Magnussen, L. de Theresa, D. Jarreta, C. Caracta, E. Garcia Gil (Grosshansdorf, Wiesbaden, Germany; Alicante, Barcelona, Spain; Jersey City, United States Of America). Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD. Eur Respir J 2013; 42: Suppl. 57, 4633

Member's Comments

No comment yet.

Related content which might interest you: Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016 Patients with severe COPD show significant improvements in dyspnea and lung function with once-daily QVA149: The BLAZE study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Lung hyperinflation in COPD: the impact of pharmacotherapy Source: Eur Respir Rev 2006; 15: 85-89 Year: 2006 The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Source: Eur Respir J 2004; 23: 832-840 Year: 2004 Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 The effect of tiotropium bromide on lung function parameters in patients with asthma- COPD overlap syndrome Source: International Congress 2016 – Asthma points to ponder Year: 2016 Tiotropium + olodaterol in patients with moderate to severe COPD with chronic bronchitis and/or emphysema Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Effect of umeclidinium/vilanterol (UMEC/VI) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patients Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Unilateral treatment with lung volume reduction coils in patients with severe emphysema Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Aclidinium bromide improves resting lung function in patients with moderate to severe COPD Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 Efficacy of tiotropium and indacaterol alone or the combination on dynamic lung hyperinflation and exercise tolerance in COPD Source: International Congress 2014 – Asthma and COPD management Year: 2014 Physiology and consequences of lung hyperinflation in COPD Source: Eur Respir Rev 2006; 15: 61-67 Year: 2006 Lung hyperinflation, dyspnoe, and exercise tolerance in patients with COPD exacerbation Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Effects of pulmonary rehabilitation on dynamic hyperinflation during exercise in severe COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 719s Year: 2005 The influence of hyperinflation and systemic inflammation on the 6 minute walking distance in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Evaluation of bronchodilator responses in patients with "irreversible" emphysema Source: Eur Respir J 2001; 18: 914-920 Year: 2001